. Author manuscript; available in PMC: 2011 Jan 10.

Published in final edited form as: Clin Pharmacol Ther. 2010 May 26;88(1):95–100. doi: 10.1038/clpt.2010.62

Table 1.

Patients’ characteristics

	Recipients
n	259
*Age (min-max)*	54±14 years (19–78)
*Sex ratio M/F*	162/97
*Cold ischemia time (min-max)*	1195±347 min (303–2580)
*Number of HLA mismatches (min-max)*	3.6±1.2 (0–6)
*Follow-up period (min-max)*	72.0±46.2 months (8.1–190.0)
*Acute rejection: n (%) with ≥ 1 episode*	80 (30.9%)
*Graft loss: n (%)*	20 (7.7%)
*Time between transplantation and graft loss (min-max)*	78.1±41.1 months (13.8–161.6)
*Delta creatinine clearance per year (ml.min⁻¹/year)*	−3.39±6.07

Parameters are expressed as mean±SD